Takayuki Miki
Tomakomai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Unilateral Graves' Disease Developing During Treatment With Tirzepatide in a Patient With Diabetes: A Case Report.
Journal: Case reports in endocrinology
Published: February 19, 2026
Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan.
Journal: Diabetology international
Published: August 22, 2023
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.
Journal: Cardiovascular drugs and therapy
Published: January 28, 2022
Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: January 04, 2022
Reduction in GLP-1 secretory capacity may be a novel independent risk factor of coronary artery stenosis.
Journal: Scientific reports
Published: February 22, 2021
Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload.
Journal: Journal of molecular and cellular cardiology
Published: October 03, 2020
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model.
Journal: Clinical and experimental nephrology
Published: August 06, 2020
Distinct intra-mitochondrial localizations of pro-survival kinases and regulation of their functions by DUSP5 and PHLPP-1.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 04, 2020
Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats.
Journal: Scientific reports
Published: November 06, 2019
Last Updated: 09/26/2026